N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide

C29H31ClN6O5 — CID 123581634

IUPACN-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide
SMILESCOc1ccc2c(c1)C(c1ccc(Cl)cc1)=NC(CC(=O)NCCNC(=O)c1cccc(O)c1O)C1NNC(C)N21
InChIInChI=1S/C29H31ClN6O5/c1-16-34-35-28-22(15-25(38)31-12-13-32-29(40)20-4-3-5-24(37)27(20)39)33-26(17-6-8-18(30)9-7-17)21-14-19(41-2)10-11-23(21)36(16)28/h3-11,14,16,22,28,34-35,37,39H,12-13,15H2,1-2H3,(H,31,38)(H,32,40)
InChIKeyPHFDKXLFQNCEJJ-UHFFFAOYSA-N
MW579.06 g/mol
LogP2.50
Rot. Bonds8

About N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide

N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide (PubChem CID 123581634) has the molecular formula C29H31ClN6O5 and a molecular weight of 579.06 g/mol. Its IUPAC name is N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide.

Molecular Properties

Compound NameN-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide
PubChem CID123581634
Molecular FormulaC29H31ClN6O5
Molecular Weight579.06 g/mol
Exact Mass578.20
IUPAC NameN-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide
SMILESCOc1ccc2c(c1)C(c1ccc(Cl)cc1)=NC(CC(=O)NCCNC(=O)c1cccc(O)c1O)C1NNC(C)N21
InChIInChI=1S/C29H31ClN6O5/c1-16-34-35-28-22(15-25(38)31-12-13-32-29(40)20-4-3-5-24(37)27(20)39)33-26(17-6-8-18(30)9-7-17)21-14-19(41-2)10-11-23(21)36(16)28/h3-11,14,16,22,28,34-35,37,39H,12-13,15H2,1-2H3,(H,31,38)(H,32,40)
InChIKeyPHFDKXLFQNCEJJ-UHFFFAOYSA-N
XLogP2.50
TPSA147.55 Ų
H-Bond Donors6
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500579.06
LogP ≤ 52.50
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}, {'alert_name': 'catechol_A(92)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}

Analyze N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide?
The IUPAC name of N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide (CID 123581634) is N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide.
What is the SMILES notation for N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide?
The canonical SMILES for N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide is COc1ccc2c(c1)C(c1ccc(Cl)cc1)=NC(CC(=O)NCCNC(=O)c1cccc(O)c1O)C1NNC(C)N21.
What is the InChIKey of N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide?
The InChIKey is PHFDKXLFQNCEJJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H31ClN6O5/c1-16-34-35-28-22(15-25(38)31-12-13-32-29(40)20-4-3-5-24(37)27(20)39)33-26(17-6-8-18(30)9-7-17)21-14-19(41-2)10-11-23(21)36(16)28/h3-11,14,16,22,28,34-35,37,39H,12-13,15H2,1-2H3,(H,31,38)(H,32,40).
What are the key properties of N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide?
N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide has a molecular weight of 579.06 g/mol, XLogP of 2.50, 8 rotatable bonds, 6 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[[2-[6-(4-chlorophenyl)-8-methoxy-1-methyl-2,3,3a,4-tetrahydro-1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetyl]amino]ethyl]-2,3-dihydroxybenzamide is sourced from PubChem (CID 123581634), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).